Efficacy and safety of nilotinib in routine healthcare: Treatment of CML patients (pts) failing prior therapy - Results of the non-interventional TARGET study

Dengler, J., Le Coutre, P., Mueller, M. C., Stegelmann, F., Ulshoeer, T., Sauer, A., Reichert, D., Schwinger, U., Waller, C. F., Schardt, C., Losem, C., Schneider-Kappus, W., Stern, S., Vehling-Kaiser, U., Meincke, M., Frank, O. and Ottmann, Oliver ORCID: https://orcid.org/0000-0001-9559-1330 2015. Efficacy and safety of nilotinib in routine healthcare: Treatment of CML patients (pts) failing prior therapy - Results of the non-interventional TARGET study. Oncology Research and Treatment 38 (S5) , pp. 132-133. 10.1159/000439070

Full text not available from this repository.

Item Type:	Article
Date Type:	Publication
Status:	Published
Schools:	Schools > Medicine
Subjects:	R Medicine > R Medicine (General)
Publisher:	Karger Publishers
ISSN:	2296-5270
Last Modified:	02 Nov 2022 09:54
URI:	https://orca.cardiff.ac.uk/id/eprint/96765

Actions (repository staff only)

Edit Item